A detailed history of Catalyst Financial Partners LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Catalyst Financial Partners LLC holds 89,699 shares of ABOS stock, worth $165,943. This represents 0.04% of its overall portfolio holdings.

Number of Shares
89,699
Previous 89,699 -0.0%
Holding current value
$165,943
Previous $217 Million 2.48%
% of portfolio
0.04%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$3.59 - $6.59 $322,019 - $591,116
89,699 New
89,699 $431 Million

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $74.9M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Catalyst Financial Partners LLC Portfolio

Follow Catalyst Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Financial Partners LLC with notifications on news.